BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32332301)

  • 1. 68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient.
    Zhao L; Gu J; Fu K; Lin Q; Chen H
    Clin Nucl Med; 2020 Oct; 45(10):e430-e432. PubMed ID: 32332301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of PET imaging of activated fibroblasts and
    Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast imaging of hepatic carcinoma with
    Shi X; Xing H; Yang X; Li F; Yao S; Zhang H; Zhao H; Hacker M; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):196-203. PubMed ID: 32468254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.
    Deng M; Chen Y; Cai L
    Clin Nucl Med; 2021 Jul; 46(7):589-591. PubMed ID: 33630809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Activation Protein-Targeted PET/CT with
    Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
    J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of [
    Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of [
    Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68Ga-FAPI PET/CT in Assessment of Leptomeningeal Metastases in a Patient With Lung Adenocarcinoma.
    Hao B; Wu J; Pang Y; Sun L; Chen H
    Clin Nucl Med; 2020 Oct; 45(10):784-786. PubMed ID: 32796242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Zhou Y; Wang Y; Song Y; Ou L; Huang Y; Deng H; Chen X
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1536-1537. PubMed ID: 36508025
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET/CT.
    Pan Q; Luo Y; Zhang W
    Clin Nucl Med; 2020 Apr; 45(4):312-313. PubMed ID: 31977476
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT.
    Luo Y; Pan Q; Zhang W; Li F
    Clin Nucl Med; 2020 Apr; 45(4):310-311. PubMed ID: 31977474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of
    Şahin E; Elboğa U; Çelen YZ; Sever ÖN; Çayırlı YB; Çimen U
    Eur J Radiol; 2021 Sep; 142():109867. PubMed ID: 34315086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma: A Case Report.
    Pang Y; Hao B; Shang Q; Sun L; Chen H
    Clin Nucl Med; 2020 Jul; 45(7):566-567. PubMed ID: 32371618
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wang H; Zhu W; Ren S; Kong Y; Huang Q; Zhao J; Guan Y; Jia H; Chen J; Lu L; Xie F; Qin L
    Front Oncol; 2021; 11():693640. PubMed ID: 34249748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.